Case todayNot read todayThesis-Break EngineThe case · strengthening · Sep 29, 2026Own CTRE if completed healthcare investments keep increasing per-share earnings while tenant credit, financing costs and new operating exposures remain controlled.6 conditions3 strengthening · 2 holding · 1 unclearNext resultsFeb 11, 2027Projected from its filing dates

CTRE at a glance

The past year

Chart

+5.2% $38.08, close Nov 13

From the highest close
−12.3%
Vs the 200-day average
−2.5%
Nov 12, 2025Daily close, CareTrust REITNov 13, 2026

Short interest

History

9.5M shares

Of shares outstanding
3.68%
Since the last report
−5.5%
Days to cover
4.1 days
Settled
Oct 30, 2026

Congress and officials

Trades

None in 90 days

Disclosed trades on record
2

Insider buying, 7 days

Filings

None filed this week

Form 4s filed
Nov 10 – Nov 16

Understand the Business

  • CareTrust owns and finances healthcare real estate, principally skilled nursing and senior housing properties in the United States and United Kingdom. Independent operators pay rent, while loans and other financing investments earn interest.↗
  • Long-term net leases transfer many property costs to tenants, but the landlord still depends on operators generating enough cash to pay rent. Healthcare reimbursement, staffing costs and tenant credit affect that capacity.↗↗

Why the Stock Moved

  • February 2026: Expansion produced per-share earnings growth: The annual results showed materially higher normalized earnings per share. Normalized FFO per share rose 17% to $1.76 for 2025, supporting confidence that completed investment was translating into shareholder-level earnings.↗
  • February 2025: Capital access supported larger investments: A larger investment quarter and expanded funding capacity increased prospective earnings power. Q4 2024 investments totaled $696.5 million and the revolver expanded to $1.2 billion, supporting more growth while leaving projected yields subject to execution.↗

CTRE price history

Latest price$37.78Today−$0.29 (-0.76%)
CTRE +3.37%S&P 500 -2.77%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

6 MATERIAL PROPOSITIONS
  • Investment growth must keep lifting per-share earnings after dilution, not just expand the asset base.StrengtheningMateriality: High

    August 6, 2026: Q2 normalized FFO and normalized FAD were both $0.51 per share, each up 19% year over year; GAAP EPS rose to $0.38 from $0.35. The per-share comparison supports accretion after a larger share count. Normalized FFO and FAD exclude items and are not substitutes for GAAP profit or operating cash.

    Watch: Watch per-share growth as more shares settle; rising total income without comparable per-share gains would weaken the case.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Both normalized per-share measures increased faster than GAAP EPS.

    Open source ↗
  • Operators and borrowers must keep meeting obligations without credit losses undermining reported income.HoldingMateriality: High

    August 6, 2026: CareTrust collected all contractual rent and interest in Q2, but recorded a $4.7 million provision for loan losses. Full collections support current payment performance; they do not eliminate future borrower risk. The provision is added back in normalized earnings and therefore deserves separate attention.

    Watch: Track missed payments, restructurings and loan-loss provisions; repeated losses despite headline collections would challenge underwriting quality.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The results report full collections and separately reconcile the loan-loss provision out of normalized earnings.

    Open source ↗
  • Completed investments must earn their projected returns before the pipeline deserves credit for future growth.StrengtheningMateriality: High

    August 6, 2026: Q2 investment activity closed at $899.6 million with an 8.9% blended stabilized yield; another $307.9 million closed afterward with a 7.8% stabilized yield. The closed volume has increased the prospective income base. Stabilized yields are not current cash returns, and the separate $540 million pipeline is not completed investment.

    Watch: Compare realized income with underwriting as assets stabilize; lower returns or delayed income would weaken the expansion thesis.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The release separates closed transactions, stabilized yield estimates and the remaining pipeline.

    Open source ↗
  • Equity settlement and borrowing must fund growth without hiding the true leverage or cost to existing shareholders.HoldingMateriality: High

    The June-end 1.01-times leverage calculation deducts $577.0 million of expected net equity-forward proceeds; August 6 disclosures still showed $671 million of gross unsettled forwards. That ratio assumes future settlement and debt reduction. It is not an unadjusted cash-and-debt measure, and settling the contracts increases the share count.

    Watch: Watch actual forward settlements, debt and diluted shares; financing that consumes investment accretion would weaken the case.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The leverage footnote assumes forward settlement and issuance of the related shares.

    Open source ↗
  • Operating cash must cover distributions while external financing remains available for the much larger investment program.StrengtheningMateriality: High

    The August 6 filing reported first-half operating cash of $225.1 million, up from $172.2 million, and common dividends paid of $163.3 million. Cash generation improved and exceeded common dividends, but $990.7 million of net investing outflows required separate funding. The Q2 76% normalized-FAD payout is not an operating-cash payout ratio.

    Watch: Watch operating cash after distributions and property needs; weaker cash conversion alongside sustained investment would raise funding dependence.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The cash-flow statement separates operating cash, dividends and investing outflows.

    Open source ↗

    The stated dividend payout ratio uses normalized FAD.

    Open source ↗
  • The UK and senior housing operating platforms must broaden earnings without introducing disproportionate currency or operating risk.UnclearMateriality: High

    The February 12 results identified UK care homes and senior housing operations as new growth platforms; by June-end the operating platform owned four communities with 372 units. These platforms enlarge the opportunity set but differ from domestic net leases. Operating expenses and exchange rates can affect income even when properties remain occupied.

    Watch: Track property-level profitability and currency effects separately; persistent losses or weak returns would undermine the diversification benefit.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The annual results identify the two added growth platforms.

    Open source ↗

    The filing describes the managed operating communities and the UK property exposure.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Investment growth must keep lifting per-share earnings after dilution, not just expand the asset base. The per-share comparison supports accretion after a larger share count. Normalized FFO and FAD exclude items and are not substitutes for GAAP profit or operating cash.

Operators and borrowers must keep meeting obligations without credit losses undermining reported income. Full collections support current payment performance; they do not eliminate future borrower risk. The provision is added back in normalized earnings and therefore deserves separate attention.

Completed investments must earn their projected returns before the pipeline deserves credit for future growth. The closed volume has increased the prospective income base. Stabilized yields are not current cash returns, and the separate $540 million pipeline is not completed investment.

Equity settlement and borrowing must fund growth without hiding the true leverage or cost to existing shareholders. That ratio assumes future settlement and debt reduction. It is not an unadjusted cash-and-debt measure, and settling the contracts increases the share count.

Operating cash must cover distributions while external financing remains available for the much larger investment program. Cash generation improved and exceeded common dividends, but $990.7 million of net investing outflows required separate funding. The Q2 76% normalized-FAD payout is not an operating-cash payout ratio.

The UK and senior housing operating platforms must broaden earnings without introducing disproportionate currency or operating risk. These platforms enlarge the opportunity set but differ from domestic net leases. Operating expenses and exchange rates can affect income even when properties remain occupied.

All standing thesis claims
Original report summary

completed healthcare investments keep increasing per-share earnings while tenant credit, financing costs and new operating exposures remain controlled.

Evidence assessed Sep 29, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Since this case

What has happened since Sep 29, 2026

The case above was written from evidence through Sep 29, 2026 and stays as written. This part is read from SEC filings and closing prices each time the page is built, so it moves as new reports are filed.

Results
Q3 2026, the quarter to Sep 30, 2026, reported Nov 5, 2026 (8-K ↗): revenue $176.4M, up 33.2% on the same quarter a year earlier; net income $83.7M. Over the 12 months to Sep 30, 2026: revenue $615.4M, net income $364.1M (59.2% of revenue).
Share price
+2.4% since Sep 29, 2026, from $37.20 to $38.08 on Nov 13, 2026. The stock alone, not measured against other companies.
Insiders
No insider transaction reported since Sep 29, 2026, as of this reading.
Conditions
None of the conditions the Thesis-Break Engine checks has crossed on CareTrust REIT since Sep 29, 2026.

Read from SEC filings and closing prices through Nov 16, 2026. A filing made today can take up to about four hours to appear here.

Bull case and bear case

Bull case and bear case for CareTrust REIT, Inc.

Where the evidence on CareTrust REIT disagrees: Strengthening on the latest evidence (Sep 29, 2026). Of its 6 thesis points, 3 strengthening, 2 holding and 1 unclear.

Bull case: what the evidence supports

Bear case: what the evidence questions

Thesis-Break Engine

Thesis-break watch · CareTrust REIT

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed CareTrust REIT’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Supportive
    Per-share growth accompanied another large investment quarter

    Q2 normalized FFO and FAD per share rose 19%. CareTrust raised 2026 normalized FFO guidance to $2.03–$2.06, assuming no additional transactions or financing beyond those already included and $147 million of loan repayments.

  2. Supportive
    The 2025 expansion translated into higher per-share earnings

    Full-year normalized FFO per share rose 17% to $1.76 after $1.8 billion of closed investment activity. UK care homes and senior housing operations expanded the platform, adding execution risks as well as growth opportunities.

Risks / falsifiers

What could break the thesis

  • Watch per-share growth as more shares settle; rising total income without comparable per-share gains would weaken the case.
  • Track missed payments, restructurings and loan-loss provisions; repeated losses despite headline collections would challenge underwriting quality.
  • Compare realized income with underwriting as assets stabilize; lower returns or delayed income would weaken the expansion thesis.
  • Watch actual forward settlements, debt and diluted shares; financing that consumes investment accretion would weaken the case.
  • Watch operating cash after distributions and property needs; weaker cash conversion alongside sustained investment would raise funding dependence.
  • Track property-level profitability and currency effects separately; persistent losses or weak returns would undermine the diversification benefit.

CTRE news

Loading headlines…

Financial statements

CTRE income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

CTRE: quick answers

When does CareTrust REIT (CTRE) report earnings next?
CareTrust REIT's next results are projected for February 11, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 5, 2026. Earnings calendar
What is CTRE's short interest?
As of October 30, 2026, 9.5M CTRE shares were sold short, 3.68% of its shares outstanding, down 5.5% from the count before. At the stock's average daily volume that is 4.1 days to cover. FINRA publishes the count twice a month. CTRE short interest history
Have members of Congress traded CTRE?
2 trades in CTRE have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed CTRE trade
ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.